Company Profile

Phase Genomics Inc
Profile last edited on: 12/8/2020      CAGE: 7BWU2      UEI: TQ67ST6YELX5

Business Identifier: Complete, accurate, detailed genomes and metagenomes
Year Founded
2015
First Award
2016
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1617 8th Avenue N
Seattle, WA 98109
   (206) 384-6228
   info@phasegenomics.com
   www.phasegenomics.com
Location: Single
Congr. District: 07
County: King

Public Profile

Phase Genomics is a University of Washington spinout organized around providing improved genome and metagenome assemblies. The firm is developing technology for ProxiMeta Hi-C genome assemby and metagenome deconvolution using leading-edge technology that exploits higher order DNA structure for improved genome and metagenome assembly. From chromosome-level genome scaffolding to assembling complete genomes from mixed populations, the firm's platform is designed to provide a rapid and affordable solution that yields unparalleled results - through more complete, affordable genomes, empowering scientists to answer biological questions not previously thought possible.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
25-49

Awards Distribution by Agency

Key People / Management

  Ivan Liachko -- Co-Founder & CEO

  Maitreya Dunham -- Co-Founder

  Stephen Matthew Eacker

  Jay Shendure -- Co-Founder

  Shawn Sullivan -- Founder and CTO

  Kayla Young -- Director of Operations